The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy
NCT00864773
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Central Serous Chorioretinopathy
Interventions
PROCEDURE:
intravitreal injection with anterior paracentesis
Sponsor
Hallym University Medical Center